ATC Group: S01ED Beta blocking agents

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of S01ED in the ATC hierarchy

Level Code Title
1 S Sensory organs
2 S01 Ophthalmologicals
3 S01E Antiglaucoma preparations and miotics
4 S01ED Beta blocking agents

Group S01ED contents

Code Title
S01ED01 Timolol
S01ED02 Betaxolol
S01ED03 Levobunolol
S01ED04 Metipranolol
S01ED05 Carteolol
S01ED06 Befunolol
S01ED51 Timolol, combinations
S01ED52 Betaxolol, combinations
S01ED54 Metipranolol, combinations
S01ED55 Carteolol, combinations

Active ingredients in S01ED

Active Ingredient

Betaxolol is a cardioselective Beta1 receptor blocker which, when applied topically to the eye, lowers intraocular pressure. It is thought to produce this effect by reducing the rate of production of aqueous humour.

Carteolol is a non-selective beta-adrenergic blocking agent with associated intrinsic sympathomimetic activity (ISA) and without significant membrane stabilizing activity. Carteolol reduces normal and elevated intraocular pressure whether or not accompanied by glaucoma.

Levobunolol is a non-cardioselective beta-adrenoceptor blocking agent, equipotent at both beta1 and beta2 receptors. The primary mechanism of action of levobunolol in reducing intraocular pressure is most likely a decrease in aqueous humor production. Levobunolol reduces intraocular pressure with little or no effect on pupil size in contrast to the miosis which cholinergic agents are known to produce.

Timolol is a non-selective beta-adrenergic receptor blocking agent that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anaesthetic activity. Timolol reduces intra-ocular pressure, whether or not this is associated with glaucoma.

Related product monographs

Document Type Information Source  
 BETAGAN Eye drops, solution MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 Betoptic Eye Drops Solution MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 BETOPTIC Eye drops, suspension MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 COMBIGAN Eye drops, solution MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 COSOPT Eye drops, solution MPI, EU: SmPC Health Products Regulatory Authority (IE)
 TIMOPTIC Ophthalmic solution MPI, US: SPL/Old FDA, National Drug Code (US)
 TIMOPTOL Eye drops, solution MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 TIOPEX Eye gel MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)